2119. Matched-Paired Analysis of Patients Treated for Invasive Mucormycosis—Standard Treatment vs. Posaconazole New Formulations (MoveOn)

BACKGROUND: Current first-line (first) antifungal treatment for invasive mucormycosis (IM) consists of liposomal amphotericin B (AMB). Salvage (SAL) treatment options are limited and often based on posaconazole oral suspension (POSsusp). However, with the approval of posaconazole new formulations (P...

Descripción completa

Detalles Bibliográficos
Autores principales: Salmanton-Garcia, Jon, Seidel, Danila, Koehler, Philipp, Mellinghoff, Sibylle, Wisplinghoff, Hilmar, Vehreschild, Jörg, Cornely, Oliver, Vehreschild, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809098/
http://dx.doi.org/10.1093/ofid/ofz360.1799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809098/
http://dx.doi.org/10.1093/ofid/ofz360.1799

Ejemplares similares